Detalhe da pesquisa
1.
Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells.
Clin Epigenetics
; 14(1): 156, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36443814
2.
DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness.
Elife
; 112022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125262
3.
Protoflavonoids from ferns impair centrosomal integrity of tumor cells.
Planta Med
; 77(5): 461-6, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20945277
4.
The centrosome protein NEDD1 as a potential pharmacological target to induce cell cycle arrest.
Mol Cancer
; 8: 10, 2009 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19243593
5.
Demethylation by low-dose 5-aza-2'-deoxycytidine impairs 3D melanoma invasion partially through miR-199a-3p expression revealing the role of this miR in melanoma.
Clin Epigenetics
; 11(1): 9, 2019 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651148
6.
DNA methyltransferase inhibitors in cancer: From pharmacology to translational studies.
Biochem Pharmacol
; 129: 1-13, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27956110
7.
DNA damage induce gamma-tubulin-RAD51 nuclear complexes in mammalian cells.
Oncogene
; 24(33): 5165-72, 2005 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-15897881
8.
Apoptotic cell death induction by F 11782 a novel dual catalytic inhibitor of topoisomerases I and II.
Biochem Pharmacol
; 65(5): 755-63, 2003 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12628489
9.
Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents.
Cancer Chemother Pharmacol
; 49(6): 479-86, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12107553
10.
F 11782, a novel catalytic inhibitor of topoisomerases I and II, induces atypical, yet cytotoxic DNA double-strand breaks in CHO-K1 cells.
Anticancer Res
; 22(1A): 187-92, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12017285
11.
Pharmacological screening of bryophyte extracts that inhibit growth and induce abnormal phenotypes in human HeLa cancer cells.
Fundam Clin Pharmacol
; 23(4): 473-82, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19709324
12.
Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues.
Bioorg Med Chem Lett
; 13(8): 1455-8, 2003 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-12668011
13.
From pure FPP to mixed FPP and CAAX competitive inhibitors of farnesyl protein transferase.
Bioorg Med Chem Lett
; 13(8): 1459-62, 2003 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-12668012